Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 49 | 2025 | 117 | 22.490 |
Why?
|
| Neuropsychological Tests | 50 | 2025 | 176 | 9.650 |
Why?
|
| Memory, Episodic | 19 | 2025 | 38 | 8.800 |
Why?
|
| Health Literacy | 14 | 2024 | 32 | 7.780 |
Why?
|
| Activities of Daily Living | 17 | 2024 | 57 | 6.570 |
Why?
|
| Executive Function | 15 | 2025 | 75 | 5.950 |
Why?
|
| Cognition | 23 | 2025 | 174 | 5.630 |
Why?
|
| Cognitive Dysfunction | 15 | 2024 | 66 | 4.890 |
Why?
|
| Humans | 87 | 2025 | 5485 | 4.790 |
Why?
|
| Memory Disorders | 12 | 2024 | 40 | 4.700 |
Why?
|
| Aged | 42 | 2024 | 860 | 4.550 |
Why?
|
| Middle Aged | 38 | 2025 | 1100 | 3.700 |
Why?
|
| Quality of Life | 7 | 2024 | 117 | 3.120 |
Why?
|
| Aging | 12 | 2024 | 127 | 2.550 |
Why?
|
| Adult | 30 | 2025 | 1687 | 2.500 |
Why?
|
| Male | 36 | 2025 | 2770 | 2.410 |
Why?
|
| Female | 36 | 2025 | 2816 | 2.400 |
Why?
|
| Periodicals as Topic | 3 | 2023 | 9 | 2.310 |
Why?
|
| Neuropsychology | 5 | 2023 | 8 | 2.140 |
Why?
|
| Internet | 5 | 2022 | 35 | 2.020 |
Why?
|
| Young Adult | 16 | 2025 | 852 | 1.920 |
Why?
|
| Memory | 4 | 2023 | 55 | 1.870 |
Why?
|
| Epilepsy | 2 | 2024 | 34 | 1.750 |
Why?
|
| Apathy | 5 | 2024 | 8 | 1.700 |
Why?
|
| Cross-Sectional Studies | 16 | 2025 | 284 | 1.670 |
Why?
|
| Aged, 80 and over | 13 | 2024 | 321 | 1.610 |
Why?
|
| Depression | 4 | 2024 | 133 | 1.600 |
Why?
|
| Consumer Health Information | 2 | 2022 | 2 | 1.510 |
Why?
|
| Attention | 3 | 2020 | 77 | 1.470 |
Why?
|
| Psychomotor Performance | 6 | 2025 | 107 | 1.440 |
Why?
|
| Cognition Disorders | 5 | 2024 | 46 | 1.230 |
Why?
|
| Cues | 4 | 2021 | 39 | 1.210 |
Why?
|
| Neurocognitive Disorders | 4 | 2023 | 6 | 1.180 |
Why?
|
| Retrospective Studies | 9 | 2025 | 382 | 1.180 |
Why?
|
| AIDS Dementia Complex | 3 | 2022 | 4 | 1.170 |
Why?
|
| Cognitive Aging | 3 | 2024 | 7 | 1.140 |
Why?
|
| Adolescent | 12 | 2024 | 806 | 1.130 |
Why?
|
| Alzheimer Disease | 3 | 2024 | 90 | 1.110 |
Why?
|
| Mental Recall | 6 | 2023 | 20 | 1.110 |
Why?
|
| Verbal Learning | 3 | 2021 | 13 | 1.080 |
Why?
|
| Telemedicine | 3 | 2022 | 37 | 1.080 |
Why?
|
| Surveys and Questionnaires | 7 | 2024 | 277 | 1.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2021 | 53 | 1.010 |
Why?
|
| Prospective Studies | 6 | 2023 | 132 | 0.980 |
Why?
|
| Biological Variation, Individual | 1 | 2025 | 1 | 0.970 |
Why?
|
| Pharmaceutical Services, Online | 2 | 2021 | 4 | 0.940 |
Why?
|
| Lewy Body Disease | 2 | 2024 | 2 | 0.910 |
Why?
|
| Independent Living | 2 | 2021 | 20 | 0.910 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2022 | 20 | 0.900 |
Why?
|
| HIV Long-Term Survivors | 1 | 2023 | 1 | 0.890 |
Why?
|
| Self Concept | 1 | 2023 | 20 | 0.870 |
Why?
|
| Patient Portals | 1 | 2023 | 3 | 0.840 |
Why?
|
| Reproducibility of Results | 9 | 2025 | 350 | 0.790 |
Why?
|
| Racism | 1 | 2021 | 17 | 0.760 |
Why?
|
| Self-Management | 1 | 2021 | 3 | 0.750 |
Why?
|
| Self Report | 4 | 2023 | 72 | 0.750 |
Why?
|
| Technology | 1 | 2021 | 7 | 0.750 |
Why?
|
| Publishing | 1 | 2020 | 2 | 0.720 |
Why?
|
| Semantics | 1 | 2021 | 26 | 0.710 |
Why?
|
| Social Environment | 1 | 2020 | 15 | 0.710 |
Why?
|
| Health Behavior | 4 | 2021 | 38 | 0.700 |
Why?
|
| Information Seeking Behavior | 1 | 2020 | 2 | 0.700 |
Why?
|
| Aptitude | 1 | 2020 | 9 | 0.700 |
Why?
|
| Intelligence | 1 | 2020 | 29 | 0.690 |
Why?
|
| Motivation | 1 | 2021 | 70 | 0.680 |
Why?
|
| Telephone | 3 | 2024 | 13 | 0.630 |
Why?
|
| Psychometrics | 5 | 2024 | 101 | 0.620 |
Why?
|
| Dementia | 1 | 2020 | 78 | 0.610 |
Why?
|
| Pandemics | 3 | 2023 | 82 | 0.550 |
Why?
|
| HIV Seronegativity | 3 | 2023 | 4 | 0.440 |
Why?
|
| Age Factors | 2 | 2024 | 75 | 0.430 |
Why?
|
| Self Efficacy | 3 | 2023 | 35 | 0.420 |
Why?
|
| Factor Analysis, Statistical | 2 | 2023 | 41 | 0.400 |
Why?
|
| Depressive Disorder, Major | 2 | 2023 | 18 | 0.390 |
Why?
|
| Pilot Projects | 2 | 2022 | 119 | 0.380 |
Why?
|
| Biomarkers | 2 | 2023 | 87 | 0.370 |
Why?
|
| Memory and Learning Tests | 2 | 2020 | 3 | 0.350 |
Why?
|
| Consensus | 3 | 2025 | 14 | 0.350 |
Why?
|
| Decision Making | 2 | 2020 | 12 | 0.340 |
Why?
|
| United States | 2 | 2021 | 522 | 0.310 |
Why?
|
| Delphi Technique | 2 | 2025 | 8 | 0.290 |
Why?
|
| Reference Values | 2 | 2024 | 28 | 0.280 |
Why?
|
| Checklist | 1 | 2025 | 3 | 0.240 |
Why?
|
| Prodromal Symptoms | 1 | 2024 | 1 | 0.240 |
Why?
|
| Science | 1 | 2024 | 7 | 0.230 |
Why?
|
| Frontotemporal Dementia | 1 | 2024 | 5 | 0.230 |
Why?
|
| Financial Management | 1 | 2024 | 3 | 0.230 |
Why?
|
| Vascular Diseases | 1 | 2024 | 4 | 0.230 |
Why?
|
| Disabled Persons | 1 | 2024 | 11 | 0.230 |
Why?
|
| Veterans | 1 | 2024 | 24 | 0.230 |
Why?
|
| Social Support | 1 | 2024 | 31 | 0.220 |
Why?
|
| Regression Analysis | 1 | 2023 | 31 | 0.220 |
Why?
|
| Interview, Psychological | 1 | 2023 | 14 | 0.220 |
Why?
|
| Psychological Tests | 1 | 2023 | 9 | 0.220 |
Why?
|
| Protective Factors | 1 | 2023 | 8 | 0.220 |
Why?
|
| Multivariate Analysis | 1 | 2023 | 19 | 0.210 |
Why?
|
| Risk Factors | 1 | 2024 | 184 | 0.210 |
Why?
|
| Health Personnel | 1 | 2023 | 22 | 0.210 |
Why?
|
| HIV | 1 | 2023 | 4 | 0.210 |
Why?
|
| tau Proteins | 1 | 2023 | 9 | 0.210 |
Why?
|
| Learning | 2 | 2020 | 50 | 0.210 |
Why?
|
| Literacy | 1 | 2022 | 2 | 0.210 |
Why?
|
| Prescription Drug Misuse | 1 | 2023 | 9 | 0.210 |
Why?
|
| Behavior, Addictive | 1 | 2022 | 10 | 0.210 |
Why?
|
| Creativity | 1 | 2022 | 3 | 0.210 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 31 | 0.200 |
Why?
|
| Intention | 1 | 2022 | 19 | 0.200 |
Why?
|
| Chronic Pain | 1 | 2023 | 23 | 0.200 |
Why?
|
| Cohort Studies | 1 | 2023 | 131 | 0.200 |
Why?
|
| Trust | 1 | 2022 | 10 | 0.200 |
Why?
|
| Post-Concussion Syndrome | 1 | 2022 | 4 | 0.200 |
Why?
|
| Substance-Related Disorders | 1 | 2022 | 52 | 0.200 |
Why?
|
| Athletic Injuries | 1 | 2022 | 4 | 0.200 |
Why?
|
| Authorship | 1 | 2021 | 4 | 0.190 |
Why?
|
| Brain Concussion | 1 | 2022 | 8 | 0.190 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 35 | 0.190 |
Why?
|
| Bibliometrics | 1 | 2021 | 9 | 0.190 |
Why?
|
| Proton Therapy | 1 | 2021 | 4 | 0.190 |
Why?
|
| Laboratories | 1 | 2021 | 5 | 0.190 |
Why?
|
| Educational Status | 1 | 2021 | 30 | 0.190 |
Why?
|
| Imagination | 1 | 2021 | 4 | 0.190 |
Why?
|
| Medication Therapy Management | 1 | 2021 | 6 | 0.190 |
Why?
|
| Individuality | 1 | 2021 | 16 | 0.190 |
Why?
|
| Chronic Disease | 1 | 2021 | 29 | 0.190 |
Why?
|
| Cancer Survivors | 1 | 2021 | 15 | 0.180 |
Why?
|
| Neurons | 1 | 2023 | 131 | 0.180 |
Why?
|
| Cluster Analysis | 1 | 2021 | 25 | 0.180 |
Why?
|
| Employment | 1 | 2021 | 10 | 0.180 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 26 | 0.180 |
Why?
|
| Acoustic Stimulation | 1 | 2021 | 21 | 0.180 |
Why?
|
| Sexism | 1 | 2020 | 3 | 0.180 |
Why?
|
| Risk-Taking | 1 | 2020 | 16 | 0.180 |
Why?
|
| Wechsler Scales | 1 | 2020 | 4 | 0.180 |
Why?
|
| Intelligence Tests | 1 | 2020 | 10 | 0.180 |
Why?
|
| Medicare | 1 | 2021 | 79 | 0.180 |
Why?
|
| Sexual Behavior | 1 | 2020 | 29 | 0.180 |
Why?
|
| Personality | 1 | 2021 | 48 | 0.180 |
Why?
|
| Child | 2 | 2021 | 657 | 0.180 |
Why?
|
| HIV Seropositivity | 1 | 2020 | 4 | 0.180 |
Why?
|
| Betacoronavirus | 1 | 2020 | 7 | 0.180 |
Why?
|
| Reaction Time | 1 | 2021 | 60 | 0.170 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 8 | 0.170 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 8 | 0.170 |
Why?
|
| Personality Disorders | 1 | 2021 | 38 | 0.170 |
Why?
|
| Comprehension | 1 | 2020 | 33 | 0.170 |
Why?
|
| Social Determinants of Health | 1 | 2020 | 10 | 0.170 |
Why?
|
| Huntington Disease | 1 | 2020 | 2 | 0.170 |
Why?
|
| Time Perception | 1 | 2019 | 5 | 0.170 |
Why?
|
| Mental Disorders | 1 | 2020 | 52 | 0.170 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 102 | 0.160 |
Why?
|
| Language | 1 | 2019 | 55 | 0.160 |
Why?
|
| Translations | 1 | 2022 | 5 | 0.050 |
Why?
|
| Translating | 1 | 2022 | 5 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 74 | 0.050 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 71 | 0.050 |
Why?
|
| Health | 1 | 2021 | 4 | 0.050 |
Why?
|
| Viral Load | 1 | 2021 | 2 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2021 | 5 | 0.050 |
Why?
|
| Photons | 1 | 2021 | 8 | 0.050 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2021 | 4 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2021 | 18 | 0.050 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 6 | 0.050 |
Why?
|
| Anxiety | 1 | 2023 | 173 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 148 | 0.040 |
Why?
|
| Depressive Disorder | 1 | 2020 | 12 | 0.040 |
Why?
|
| Disease Progression | 1 | 2020 | 74 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2021 | 72 | 0.040 |
Why?
|